CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −3,925 | $1.11 | $4K | 88,273 |
| 2025-10-14 | Pinto Shelly SVP, FINANCE AND CAO | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2025-10-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +597,500 | 597,500 | ||
| 2025-10-14 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +198,750 | 198,750 | ||
| 2025-09-17 | Klencke Barbara Director | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2025-09-17 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Purchase | +71,163 | $1.08 | $77K | 305,121 |
| 2025-09-16 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Purchase | +21,070 | $1.07 | $22K | 233,958 |
| 2025-08-18 | Shantharam Harish Chief Financial Officer | Purchase | +75,000 | $0.78 | $58K | 75,000 |
| 2025-08-15 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −611 | $0.64 | $391 | 89,198 |
| 2025-08-15 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −2,382 | $0.64 | $2K | 212,888 |
| 2025-08-12 | Curran Daniel J. Director | Grant or award · Stock option (right to buy) | +40,400 | 40,400 | ||
| 2025-07-07 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −2,011 | $0.45 | $905 | 86,809 |
| 2025-06-30 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −1,532 | $0.43 | $659 | 88,820 |
| 2025-04-11 | Pinto Shelly SVP, FINANCE AND CAO | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-04-11 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-04-11 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-04-11 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-03-14 | Pinto Shelly SVP, FINANCE AND CAO | Grant or award | +3,000 | 90,352 | ||
| 2025-03-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award | +42,000 | 212,270 | ||
| 2025-02-19 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −550 | $1.15 | $633 | 87,352 |
Page 2 of 22 · 432 trades